Doximity, Inc. (DOCS)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	10,745	10,889	5,020	6,268	9,966	-
Market Cap Growth	116.90%	116.90%	-19.91%	-37.10%	-	-
Enterprise Value	9,841	10,057	4,325	5,483	9,202	-
Last Close Price	57.33	58.03	26.91	32.38	52.09	-
PE Ratio	51.65	48.79	34.02	55.56	74.78	-
Forward PE	39.58	42.92	29.34	43.81	82.17	-
PS Ratio	18.78	19.09	10.56	14.96	29.01	-
PB Ratio	10.00	10.06	5.57	6.49	11.34	-
P/TBV Ratio	10.84	10.98	6.23	7.24	11.70	-
P/FCF Ratio	39.32	39.85	27.29	35.24	79.94	-
P/OCF Ratio	39.32	39.85	27.27	34.90	78.73	-
PEG Ratio	4.29	2.32	2.85	13.05	10.99	-
EV/Sales Ratio	17.25	17.63	9.10	13.09	26.78	-
EV/EBITDA Ratio	41.76	42.68	24.29	41.75	79.79	-
EV/EBIT Ratio	42.64	43.58	25.03	43.56	80.86	-
EV/FCF Ratio	36.01	36.80	23.51	30.82	73.81	-
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.00	0.01
Debt / EBITDA Ratio	0.05	0.05	0.08	0.12	0.01	0.02
Debt / FCF Ratio	0.05	0.05	0.08	0.09	0.01	0.02
Asset Turnover	0.49	0.49	0.43	0.39	0.55	1.06
Quick Ratio	6.73	6.73	5.91	6.83	7.93	1.90
Current Ratio	6.97	6.97	6.20	6.99	8.13	2.05
Return on Equity (ROE)	22.50%	22.50%	15.80%	12.23%	30.15%	43.51%
Return on Assets (ROA)	12.31%	12.31%	9.74%	7.39%	11.44%	17.21%
Return on Capital (ROIC)	14.34%	14.34%	11.38%	8.45%	13.82%	28.70%
Return on Capital Employed (ROCE)	20.80%	20.80%	18.50%	12.60%	12.90%	35.90%
Earnings Yield	2.08%	2.05%	2.94%	1.80%	1.55%	-
FCF Yield	2.54%	2.51%	3.66%	2.84%	1.25%	-
Buyback Yield / Dilution	2.20%	2.20%	3.60%	-11.73%	-100.79%	-16.43%

Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q